Atlas Trials

Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer

Clinical trial NCT04683445 · UNKNOWN

Trial details

NCT number
NCT04683445
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2020-12-01
Primary completion
2022-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.